Management of Hepatitis B with Siddha Herbal Drug Manjal Noi Kudineer - A Case Study

A Single Case Clinical Trial on the Siddha Management of Perumanjal Noi (Hepatitis B) with Drug of Choice - Manjal Noi Kudineer among Patients Attending OPD at Government Siddha Medical College Hospital, Chennai - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057465

Enrollment

Registered

2023-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B181- Chronic viral hepatitis B withoutdelta-agent

Interventions

Intervention1: Manjal Noi Kudineer- siddha herbal drug: Its a formulation of 6 Herbal drugs indicated for PERUMANJAL NOI ( hepatitis B) from sigicha ratna deepam part 1 (siddha literature) Preparatio

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who are positive for HBsAg with increased viral load above 250 IU/mL.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Children and adolescents 3.K/C/O Cirrhosis of liver 4.K/C/O Ca of liver

Design outcomes

Primary

Measure	Time frame
Reduction in HBsAg viral loadTimepoint: Primary outcome can be expected in a duration of 12 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Anbu N

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026